InGel Therapeutics, Inc.
InGel Therapeutics, Inc. is a cell Therapy for Sight Loss founded in 2022.
1
Funding Rounds
$1.0m
Money raised
Overview
InGel Therapeutics, Inc. is a cell Therapy for Sight Loss founded in 2022.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company InGel Therapeutics, Inc. has raised a total of $1m in funding over 1 rounds.
Key Insights:
- InGel Therapeutics, Inc. Funding Round, August 2022: $1m
InGel Therapeutics, Inc. Funding Round, August 2022
$1m
Industries
InGel Therapeutics, Inc. is active in the following industries: